These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7597329)

  • 1. [Anti HTLV-I antibody titers in seropositive infected individuals].
    Galeno H; Ramírez E; Mora J; Ojeda M; Cartier L
    Rev Med Chil; 1994 Sep; 122(9):1004-7. PubMed ID: 7597329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
    Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
    J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies against HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers.
    Minagawa H; Yoshida T; Itoyama Y; Mora CA; Albert P; Mori R
    Neurology; 1992 Nov; 42(11):2210-2. PubMed ID: 1436540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of anti-HTLV-I antibody titer in cerebrospinal fluid].
    Nakajima O; Honna T; Ueno J; Araki K; Matsuno K; Matsumiya H; Togashi T; Shibata M; Sakurada K; Miyazaki T
    Rinsho Byori; 1989 Sep; 37(9):1029-32. PubMed ID: 2607656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews.
    Achiron A; Pinhas-Hamiel O; Doll L; Djaldetti R; Chen A; Ziv I; Avni A; Frankel G; Melamed E; Shohat B
    Ann Neurol; 1993 Nov; 34(5):670-5. PubMed ID: 8239561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenetic significance of HTLV-I infection and immune surveillance in HAM].
    Fujihara K
    Rinsho Shinkeigaku; 1999 Jan; 39(1):21-3. PubMed ID: 10377790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study.
    van der Ryst E; Joubert G; Smith MS; Terblanche M; Mollentze F; Pretorius AM
    Cent Afr J Med; 1996 Mar; 42(3):65-8. PubMed ID: 8653770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
    Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
    J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin A.
    Andrada-Serpa MJ; Schor D; Araújo AQ; Rumjanek VM
    J Neurol Sci; 1996 Jul; 139(1):7-14. PubMed ID: 8836966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers.
    Akimoto M; Kozako T; Sawada T; Matsushita K; Ozaki A; Hamada H; Kawada H; Yoshimitsu M; Tokunaga M; Haraguchi K; Uozumi K; Arima N; Tei C
    J Med Virol; 2007 Jul; 79(7):977-86. PubMed ID: 17516523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
    Saito M; Eiraku N; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2005 May; 232(1-2):29-35. PubMed ID: 15850579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on HTLV-I associated myelopathy in Argentina.
    Gonzalez LA; Villa AM; Kohler G; Garcea O; Kremenchutzky M; Caceres F; Sanz OP; Sica RE
    Medicina (B Aires); 1998; 58(4):411-4. PubMed ID: 9816704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of in vitro lymphoproliferative responses among HTLV-1-infected subjects: upregulation by HTLV-1 during HIV-1 co-infection.
    Olah I; Fukumori LM; Montanheiro P; Vergara MP; Smid J; Duarte AJ; Penalva de Oliveira AC; Casseb J
    Scand J Immunol; 2007 Jun; 65(6):577-80. PubMed ID: 17523951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal molecular mimicry in immune-mediated neurologic disease.
    Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
    Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.